Clinical Trial Update: Apremilast for Erythema Multiforme [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating apremilast for erythema multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Multiforme

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Robert Micheletti | Conditions: Erythema Multiforme | Phase 2 | Status: COMPLETED